Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, United States; Department of Psychiatry, Harvard Medical School, Boston, United States
Kiersten S Smith
Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, United States; Department of Psychiatry, Harvard Medical School, Boston, United States
Yudong Gao
Department of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, United States
David Nagy
Section of Comparative Medicine, Yale School of Medicine, New Haven, United States
Rachel A Foster
Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, United States; Department of Psychiatry, Harvard Medical School, Boston, United States
Evgeny Tsvetkov
Department of Psychiatry, Harvard Medical School, Boston, United States; Cellular Neurobiology Laboratory, McLean Hospital, Belmont, United States; Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, St. Petersburg, Russia
Ruth Keist
Institute for Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
Florence Crestani
Institute for Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
Jean-Marc Fritschy
Institute for Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
Vadim Y Bolshakov
Department of Psychiatry, Harvard Medical School, Boston, United States; Cellular Neurobiology Laboratory, McLean Hospital, Belmont, United States
Mihaly Hajos
Section of Comparative Medicine, Yale School of Medicine, New Haven, United States
Scott A Heldt
Department of Anatomy and Neurobiology, The University of Tennessee Health Science Center, Memphis, United States
Uwe Rudolph
Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, United States; Department of Psychiatry, Harvard Medical School, Boston, United States
Recent findings indicate a high level of specialization at the level of microcircuits and cell populations within brain structures with regards to the control of fear and anxiety. The hippocampus, however, has been treated as a unitary structure in anxiety and fear research despite mounting evidence that different hippocampal subregions have specialized roles in other cognitive domains. Using novel cell-type- and region-specific conditional knockouts of the GABAA receptor α2 subunit, we demonstrate that inhibition of the principal neurons of the dentate gyrus and CA3 via α2-containing GABAA receptors (α2GABAARs) is required to suppress anxiety, while the inhibition of CA1 pyramidal neurons is required to suppress fear responses. We further show that the diazepam-modulation of hippocampal theta activity shows certain parallels with our behavioral findings, suggesting a possible mechanism for the observed behavioral effects. Thus, our findings demonstrate a double dissociation in the regulation of anxiety versus fear by hippocampal microcircuitry.